nodes	percent_of_prediction	percent_of_DWPC	metapath
Lercanidipine—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.0247	0.0394	CbGbCtD
Lercanidipine—CYP3A7—Ifosfamide—hematologic cancer	0.0247	0.0394	CbGbCtD
Lercanidipine—CYP3A7—Imatinib—hematologic cancer	0.0236	0.0376	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.0236	0.0376	CbGbCtD
Lercanidipine—CYP3A5—Daunorubicin—hematologic cancer	0.0231	0.0368	CbGbCtD
Lercanidipine—CYP2D6—Lomustine—hematologic cancer	0.0225	0.0358	CbGbCtD
Lercanidipine—CYP3A5—Thalidomide—hematologic cancer	0.021	0.0335	CbGbCtD
Lercanidipine—CYP3A5—Teniposide—hematologic cancer	0.0201	0.032	CbGbCtD
Lercanidipine—CYP2D6—Idarubicin—hematologic cancer	0.02	0.0319	CbGbCtD
Lercanidipine—CYP3A5—Ifosfamide—hematologic cancer	0.0185	0.0295	CbGbCtD
Lercanidipine—CYP3A5—Imatinib—hematologic cancer	0.0177	0.0282	CbGbCtD
Lercanidipine—CYP2D6—Hydroxyurea—hematologic cancer	0.017	0.0271	CbGbCtD
Lercanidipine—CYP3A4—Bexarotene—hematologic cancer	0.0154	0.0245	CbGbCtD
Lercanidipine—CYP2D6—Bortezomib—hematologic cancer	0.0148	0.0236	CbGbCtD
Lercanidipine—CYP3A7—Irinotecan—hematologic cancer	0.0147	0.0235	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.0147	0.0235	CbGbCtD
Lercanidipine—CYP3A4—Lomustine—hematologic cancer	0.0143	0.0228	CbGbCtD
Lercanidipine—CYP3A4—Busulfan—hematologic cancer	0.0143	0.0228	CbGbCtD
Lercanidipine—CYP3A5—Dasatinib—hematologic cancer	0.0142	0.0227	CbGbCtD
Lercanidipine—CYP3A7—Vincristine—hematologic cancer	0.0129	0.0205	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.0129	0.0205	CbGbCtD
Lercanidipine—CYP3A4—Thiotepa—hematologic cancer	0.0127	0.0203	CbGbCtD
Lercanidipine—CYP3A5—Irinotecan—hematologic cancer	0.0111	0.0176	CbGbCtD
Lercanidipine—CYP2D6—Imatinib—hematologic cancer	0.0109	0.0173	CbGbCtD
Lercanidipine—CYP3A4—Methoxsalen—hematologic cancer	0.00991	0.0158	CbGbCtD
Lercanidipine—CYP2D6—Nilotinib—hematologic cancer	0.00986	0.0157	CbGbCtD
Lercanidipine—CYP2D6—Vinorelbine—hematologic cancer	0.00978	0.0156	CbGbCtD
Lercanidipine—CYP3A7—Dexamethasone—hematologic cancer	0.00971	0.0155	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00971	0.0155	CbGbCtD
Lercanidipine—CYP3A5—Vincristine—hematologic cancer	0.00966	0.0154	CbGbCtD
Lercanidipine—CYP3A4—Bortezomib—hematologic cancer	0.00942	0.015	CbGbCtD
Lercanidipine—CYP3A4—Daunorubicin—hematologic cancer	0.00901	0.0144	CbGbCtD
Lercanidipine—CYP3A5—Etoposide—hematologic cancer	0.00886	0.0141	CbGbCtD
Lercanidipine—CYP3A4—Cytarabine—hematologic cancer	0.00795	0.0127	CbGbCtD
Lercanidipine—CYP3A4—Teniposide—hematologic cancer	0.00783	0.0125	CbGbCtD
Lercanidipine—CYP3A5—Dexamethasone—hematologic cancer	0.00728	0.0116	CbGbCtD
Lercanidipine—CYP3A4—Ifosfamide—hematologic cancer	0.00723	0.0115	CbGbCtD
Lercanidipine—CYP3A4—Imatinib—hematologic cancer	0.0069	0.011	CbGbCtD
Lercanidipine—CYP3A4—Ruxolitinib—hematologic cancer	0.0065	0.0104	CbGbCtD
Lercanidipine—CYP3A4—Nilotinib—hematologic cancer	0.00627	0.01	CbGbCtD
Lercanidipine—CYP3A4—Vinorelbine—hematologic cancer	0.00622	0.00991	CbGbCtD
Lercanidipine—CYP2D6—Vinblastine—hematologic cancer	0.00603	0.00961	CbGbCtD
Lercanidipine—CYP3A4—Triamcinolone—hematologic cancer	0.00569	0.00907	CbGbCtD
Lercanidipine—CYP3A4—Dasatinib—hematologic cancer	0.00554	0.00883	CbGbCtD
Lercanidipine—CYP3A4—Mitoxantrone—hematologic cancer	0.00548	0.00873	CbGbCtD
Lercanidipine—CYP3A4—Betamethasone—hematologic cancer	0.00488	0.00778	CbGbCtD
Lercanidipine—CYP3A4—Prednisolone—hematologic cancer	0.00482	0.00767	CbGbCtD
Lercanidipine—CYP3A4—Prednisone—hematologic cancer	0.00455	0.00725	CbGbCtD
Lercanidipine—CYP2D6—Dexamethasone—hematologic cancer	0.00446	0.00712	CbGbCtD
Lercanidipine—CYP3A4—Irinotecan—hematologic cancer	0.00431	0.00687	CbGbCtD
Lercanidipine—CYP3A4—Vinblastine—hematologic cancer	0.00383	0.00611	CbGbCtD
Lercanidipine—CYP3A4—Vincristine—hematologic cancer	0.00377	0.00601	CbGbCtD
Lercanidipine—CYP2D6—Doxorubicin—hematologic cancer	0.0037	0.0059	CbGbCtD
Lercanidipine—CYP3A4—Etoposide—hematologic cancer	0.00345	0.0055	CbGbCtD
Lercanidipine—CYP3A4—Dexamethasone—hematologic cancer	0.00284	0.00452	CbGbCtD
Lercanidipine—CYP3A4—Doxorubicin—hematologic cancer	0.00236	0.00375	CbGbCtD
Lercanidipine—Nifedipine—ABCC3—hematologic cancer	0.000501	0.464	CrCbGaD
Lercanidipine—Nisoldipine—ABCB1—hematologic cancer	0.000141	0.13	CrCbGaD
Lercanidipine—Nitrendipine—ABCB1—hematologic cancer	0.000132	0.122	CrCbGaD
Lercanidipine—Felodipine—ABCB1—hematologic cancer	0.000105	0.0971	CrCbGaD
Lercanidipine—Nifedipine—ABCB1—hematologic cancer	0.000101	0.0939	CrCbGaD
Lercanidipine—Nicardipine—ABCB1—hematologic cancer	9.97e-05	0.0924	CrCbGaD
Lercanidipine—Fatigue—Betamethasone—hematologic cancer	3.08e-05	9.72e-05	CcSEcCtD
Lercanidipine—Pruritus—Etoposide—hematologic cancer	3.07e-05	9.69e-05	CcSEcCtD
Lercanidipine—Shock—Prednisone—hematologic cancer	3.06e-05	9.66e-05	CcSEcCtD
Lercanidipine—Nervous system disorder—Prednisone—hematologic cancer	3.05e-05	9.63e-05	CcSEcCtD
Lercanidipine—Tachycardia—Prednisone—hematologic cancer	3.04e-05	9.58e-05	CcSEcCtD
Lercanidipine—Alopecia—Epirubicin—hematologic cancer	3.03e-05	9.55e-05	CcSEcCtD
Lercanidipine—Skin disorder—Prednisone—hematologic cancer	3.02e-05	9.54e-05	CcSEcCtD
Lercanidipine—Nausea—Gemcitabine—hematologic cancer	3.02e-05	9.53e-05	CcSEcCtD
Lercanidipine—Vomiting—Cisplatin—hematologic cancer	3.01e-05	9.51e-05	CcSEcCtD
Lercanidipine—Hyperhidrosis—Prednisone—hematologic cancer	3.01e-05	9.49e-05	CcSEcCtD
Lercanidipine—Vision blurred—Methotrexate—hematologic cancer	3e-05	9.47e-05	CcSEcCtD
Lercanidipine—Mental disorder—Epirubicin—hematologic cancer	3e-05	9.47e-05	CcSEcCtD
Lercanidipine—Erythema multiforme—Doxorubicin—hematologic cancer	3e-05	9.45e-05	CcSEcCtD
Lercanidipine—Rash—Cisplatin—hematologic cancer	2.99e-05	9.43e-05	CcSEcCtD
Lercanidipine—Dermatitis—Cisplatin—hematologic cancer	2.99e-05	9.42e-05	CcSEcCtD
Lercanidipine—Erythema—Epirubicin—hematologic cancer	2.98e-05	9.41e-05	CcSEcCtD
Lercanidipine—Malnutrition—Epirubicin—hematologic cancer	2.98e-05	9.41e-05	CcSEcCtD
Lercanidipine—Diarrhoea—Etoposide—hematologic cancer	2.97e-05	9.37e-05	CcSEcCtD
Lercanidipine—Anorexia—Prednisone—hematologic cancer	2.97e-05	9.36e-05	CcSEcCtD
Lercanidipine—Eye disorder—Doxorubicin—hematologic cancer	2.96e-05	9.34e-05	CcSEcCtD
Lercanidipine—Ill-defined disorder—Methotrexate—hematologic cancer	2.96e-05	9.33e-05	CcSEcCtD
Lercanidipine—Tinnitus—Doxorubicin—hematologic cancer	2.96e-05	9.32e-05	CcSEcCtD
Lercanidipine—Anaemia—Methotrexate—hematologic cancer	2.95e-05	9.29e-05	CcSEcCtD
Lercanidipine—Feeling abnormal—Dexamethasone—hematologic cancer	2.94e-05	9.29e-05	CcSEcCtD
Lercanidipine—Feeling abnormal—Betamethasone—hematologic cancer	2.94e-05	9.29e-05	CcSEcCtD
Lercanidipine—Cardiac disorder—Doxorubicin—hematologic cancer	2.94e-05	9.28e-05	CcSEcCtD
Lercanidipine—Flushing—Doxorubicin—hematologic cancer	2.94e-05	9.28e-05	CcSEcCtD
Lercanidipine—Tension—Epirubicin—hematologic cancer	2.93e-05	9.23e-05	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.92e-05	9.22e-05	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Betamethasone—hematologic cancer	2.92e-05	9.22e-05	CcSEcCtD
Lercanidipine—Dysgeusia—Epirubicin—hematologic cancer	2.92e-05	9.21e-05	CcSEcCtD
Lercanidipine—Hypersensitivity—Triamcinolone—hematologic cancer	2.9e-05	9.15e-05	CcSEcCtD
Lercanidipine—Nervousness—Epirubicin—hematologic cancer	2.9e-05	9.14e-05	CcSEcCtD
Lercanidipine—Angiopathy—Doxorubicin—hematologic cancer	2.88e-05	9.07e-05	CcSEcCtD
Lercanidipine—Malaise—Methotrexate—hematologic cancer	2.87e-05	9.07e-05	CcSEcCtD
Lercanidipine—Dizziness—Etoposide—hematologic cancer	2.87e-05	9.06e-05	CcSEcCtD
Lercanidipine—Muscle spasms—Epirubicin—hematologic cancer	2.87e-05	9.04e-05	CcSEcCtD
Lercanidipine—Immune system disorder—Doxorubicin—hematologic cancer	2.86e-05	9.03e-05	CcSEcCtD
Lercanidipine—Vertigo—Methotrexate—hematologic cancer	2.86e-05	9.03e-05	CcSEcCtD
Lercanidipine—Mediastinal disorder—Doxorubicin—hematologic cancer	2.86e-05	9.01e-05	CcSEcCtD
Lercanidipine—Urticaria—Dexamethasone—hematologic cancer	2.84e-05	8.95e-05	CcSEcCtD
Lercanidipine—Urticaria—Betamethasone—hematologic cancer	2.84e-05	8.95e-05	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.84e-05	8.94e-05	CcSEcCtD
Lercanidipine—Dizziness—Prednisolone—hematologic cancer	2.83e-05	8.93e-05	CcSEcCtD
Lercanidipine—Asthenia—Triamcinolone—hematologic cancer	2.83e-05	8.91e-05	CcSEcCtD
Lercanidipine—Abdominal pain—Dexamethasone—hematologic cancer	2.82e-05	8.91e-05	CcSEcCtD
Lercanidipine—Body temperature increased—Dexamethasone—hematologic cancer	2.82e-05	8.91e-05	CcSEcCtD
Lercanidipine—Abdominal pain—Betamethasone—hematologic cancer	2.82e-05	8.91e-05	CcSEcCtD
Lercanidipine—Body temperature increased—Betamethasone—hematologic cancer	2.82e-05	8.91e-05	CcSEcCtD
Lercanidipine—Nausea—Cisplatin—hematologic cancer	2.82e-05	8.88e-05	CcSEcCtD
Lercanidipine—Insomnia—Prednisone—hematologic cancer	2.81e-05	8.88e-05	CcSEcCtD
Lercanidipine—Vision blurred—Epirubicin—hematologic cancer	2.81e-05	8.87e-05	CcSEcCtD
Lercanidipine—Alopecia—Doxorubicin—hematologic cancer	2.8e-05	8.84e-05	CcSEcCtD
Lercanidipine—Paraesthesia—Prednisone—hematologic cancer	2.79e-05	8.81e-05	CcSEcCtD
Lercanidipine—Pruritus—Triamcinolone—hematologic cancer	2.79e-05	8.79e-05	CcSEcCtD
Lercanidipine—Cough—Methotrexate—hematologic cancer	2.78e-05	8.77e-05	CcSEcCtD
Lercanidipine—Mental disorder—Doxorubicin—hematologic cancer	2.78e-05	8.76e-05	CcSEcCtD
Lercanidipine—Ill-defined disorder—Epirubicin—hematologic cancer	2.77e-05	8.73e-05	CcSEcCtD
Lercanidipine—Vomiting—Etoposide—hematologic cancer	2.76e-05	8.71e-05	CcSEcCtD
Lercanidipine—Erythema—Doxorubicin—hematologic cancer	2.76e-05	8.7e-05	CcSEcCtD
Lercanidipine—Malnutrition—Doxorubicin—hematologic cancer	2.76e-05	8.7e-05	CcSEcCtD
Lercanidipine—Anaemia—Epirubicin—hematologic cancer	2.76e-05	8.69e-05	CcSEcCtD
Lercanidipine—Dyspepsia—Prednisone—hematologic cancer	2.74e-05	8.64e-05	CcSEcCtD
Lercanidipine—Rash—Etoposide—hematologic cancer	2.74e-05	8.64e-05	CcSEcCtD
Lercanidipine—Dermatitis—Etoposide—hematologic cancer	2.74e-05	8.63e-05	CcSEcCtD
Lercanidipine—Headache—Etoposide—hematologic cancer	2.72e-05	8.58e-05	CcSEcCtD
Lercanidipine—Chest pain—Methotrexate—hematologic cancer	2.71e-05	8.56e-05	CcSEcCtD
Lercanidipine—Myalgia—Methotrexate—hematologic cancer	2.71e-05	8.56e-05	CcSEcCtD
Lercanidipine—Arthralgia—Methotrexate—hematologic cancer	2.71e-05	8.56e-05	CcSEcCtD
Lercanidipine—Tension—Doxorubicin—hematologic cancer	2.71e-05	8.54e-05	CcSEcCtD
Lercanidipine—Decreased appetite—Prednisone—hematologic cancer	2.71e-05	8.53e-05	CcSEcCtD
Lercanidipine—Dysgeusia—Doxorubicin—hematologic cancer	2.7e-05	8.52e-05	CcSEcCtD
Lercanidipine—Rash—Prednisolone—hematologic cancer	2.7e-05	8.52e-05	CcSEcCtD
Lercanidipine—Dermatitis—Prednisolone—hematologic cancer	2.7e-05	8.51e-05	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.69e-05	8.5e-05	CcSEcCtD
Lercanidipine—Malaise—Epirubicin—hematologic cancer	2.69e-05	8.48e-05	CcSEcCtD
Lercanidipine—Fatigue—Prednisone—hematologic cancer	2.68e-05	8.46e-05	CcSEcCtD
Lercanidipine—Headache—Prednisolone—hematologic cancer	2.68e-05	8.46e-05	CcSEcCtD
Lercanidipine—Discomfort—Methotrexate—hematologic cancer	2.68e-05	8.46e-05	CcSEcCtD
Lercanidipine—Nervousness—Doxorubicin—hematologic cancer	2.68e-05	8.45e-05	CcSEcCtD
Lercanidipine—Vertigo—Epirubicin—hematologic cancer	2.68e-05	8.45e-05	CcSEcCtD
Lercanidipine—Syncope—Epirubicin—hematologic cancer	2.67e-05	8.44e-05	CcSEcCtD
Lercanidipine—Constipation—Prednisone—hematologic cancer	2.66e-05	8.39e-05	CcSEcCtD
Lercanidipine—Muscle spasms—Doxorubicin—hematologic cancer	2.65e-05	8.37e-05	CcSEcCtD
Lercanidipine—Palpitations—Epirubicin—hematologic cancer	2.64e-05	8.31e-05	CcSEcCtD
Lercanidipine—Confusional state—Methotrexate—hematologic cancer	2.62e-05	8.27e-05	CcSEcCtD
Lercanidipine—Loss of consciousness—Epirubicin—hematologic cancer	2.62e-05	8.27e-05	CcSEcCtD
Lercanidipine—Dizziness—Triamcinolone—hematologic cancer	2.6e-05	8.22e-05	CcSEcCtD
Lercanidipine—Cough—Epirubicin—hematologic cancer	2.6e-05	8.21e-05	CcSEcCtD
Lercanidipine—Vision blurred—Doxorubicin—hematologic cancer	2.6e-05	8.2e-05	CcSEcCtD
Lercanidipine—Nausea—Etoposide—hematologic cancer	2.58e-05	8.14e-05	CcSEcCtD
Lercanidipine—Feeling abnormal—Prednisone—hematologic cancer	2.56e-05	8.09e-05	CcSEcCtD
Lercanidipine—Asthenia—Betamethasone—hematologic cancer	2.56e-05	8.09e-05	CcSEcCtD
Lercanidipine—Asthenia—Dexamethasone—hematologic cancer	2.56e-05	8.09e-05	CcSEcCtD
Lercanidipine—Ill-defined disorder—Doxorubicin—hematologic cancer	2.56e-05	8.08e-05	CcSEcCtD
Lercanidipine—Nervous system disorder—Methotrexate—hematologic cancer	2.55e-05	8.05e-05	CcSEcCtD
Lercanidipine—Anaemia—Doxorubicin—hematologic cancer	2.55e-05	8.05e-05	CcSEcCtD
Lercanidipine—Thrombocytopenia—Methotrexate—hematologic cancer	2.55e-05	8.03e-05	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Prednisone—hematologic cancer	2.54e-05	8.03e-05	CcSEcCtD
Lercanidipine—Nausea—Prednisolone—hematologic cancer	2.54e-05	8.02e-05	CcSEcCtD
Lercanidipine—Arthralgia—Epirubicin—hematologic cancer	2.54e-05	8.01e-05	CcSEcCtD
Lercanidipine—Chest pain—Epirubicin—hematologic cancer	2.54e-05	8.01e-05	CcSEcCtD
Lercanidipine—Myalgia—Epirubicin—hematologic cancer	2.54e-05	8.01e-05	CcSEcCtD
Lercanidipine—Anxiety—Epirubicin—hematologic cancer	2.53e-05	7.98e-05	CcSEcCtD
Lercanidipine—Pruritus—Dexamethasone—hematologic cancer	2.53e-05	7.98e-05	CcSEcCtD
Lercanidipine—Pruritus—Betamethasone—hematologic cancer	2.53e-05	7.98e-05	CcSEcCtD
Lercanidipine—Skin disorder—Methotrexate—hematologic cancer	2.53e-05	7.97e-05	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.52e-05	7.95e-05	CcSEcCtD
Lercanidipine—Hyperhidrosis—Methotrexate—hematologic cancer	2.51e-05	7.93e-05	CcSEcCtD
Lercanidipine—Discomfort—Epirubicin—hematologic cancer	2.51e-05	7.91e-05	CcSEcCtD
Lercanidipine—Vomiting—Triamcinolone—hematologic cancer	2.5e-05	7.9e-05	CcSEcCtD
Lercanidipine—Malaise—Doxorubicin—hematologic cancer	2.49e-05	7.85e-05	CcSEcCtD
Lercanidipine—Rash—Triamcinolone—hematologic cancer	2.48e-05	7.83e-05	CcSEcCtD
Lercanidipine—Dry mouth—Epirubicin—hematologic cancer	2.48e-05	7.83e-05	CcSEcCtD
Lercanidipine—Dermatitis—Triamcinolone—hematologic cancer	2.48e-05	7.83e-05	CcSEcCtD
Lercanidipine—Vertigo—Doxorubicin—hematologic cancer	2.48e-05	7.82e-05	CcSEcCtD
Lercanidipine—Anorexia—Methotrexate—hematologic cancer	2.48e-05	7.82e-05	CcSEcCtD
Lercanidipine—Syncope—Doxorubicin—hematologic cancer	2.47e-05	7.81e-05	CcSEcCtD
Lercanidipine—Urticaria—Prednisone—hematologic cancer	2.47e-05	7.8e-05	CcSEcCtD
Lercanidipine—Headache—Triamcinolone—hematologic cancer	2.47e-05	7.78e-05	CcSEcCtD
Lercanidipine—Body temperature increased—Prednisone—hematologic cancer	2.46e-05	7.76e-05	CcSEcCtD
Lercanidipine—Abdominal pain—Prednisone—hematologic cancer	2.46e-05	7.76e-05	CcSEcCtD
Lercanidipine—Confusional state—Epirubicin—hematologic cancer	2.45e-05	7.74e-05	CcSEcCtD
Lercanidipine—Diarrhoea—Betamethasone—hematologic cancer	2.44e-05	7.71e-05	CcSEcCtD
Lercanidipine—Diarrhoea—Dexamethasone—hematologic cancer	2.44e-05	7.71e-05	CcSEcCtD
Lercanidipine—Palpitations—Doxorubicin—hematologic cancer	2.44e-05	7.69e-05	CcSEcCtD
Lercanidipine—Hypotension—Methotrexate—hematologic cancer	2.43e-05	7.67e-05	CcSEcCtD
Lercanidipine—Loss of consciousness—Doxorubicin—hematologic cancer	2.43e-05	7.65e-05	CcSEcCtD
Lercanidipine—Cough—Doxorubicin—hematologic cancer	2.41e-05	7.6e-05	CcSEcCtD
Lercanidipine—Shock—Epirubicin—hematologic cancer	2.39e-05	7.55e-05	CcSEcCtD
Lercanidipine—Nervous system disorder—Epirubicin—hematologic cancer	2.39e-05	7.53e-05	CcSEcCtD
Lercanidipine—Thrombocytopenia—Epirubicin—hematologic cancer	2.38e-05	7.52e-05	CcSEcCtD
Lercanidipine—Tachycardia—Epirubicin—hematologic cancer	2.38e-05	7.49e-05	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.37e-05	7.47e-05	CcSEcCtD
Lercanidipine—Skin disorder—Epirubicin—hematologic cancer	2.36e-05	7.46e-05	CcSEcCtD
Lercanidipine—Dizziness—Betamethasone—hematologic cancer	2.36e-05	7.45e-05	CcSEcCtD
Lercanidipine—Dizziness—Dexamethasone—hematologic cancer	2.36e-05	7.45e-05	CcSEcCtD
Lercanidipine—Hyperhidrosis—Epirubicin—hematologic cancer	2.35e-05	7.42e-05	CcSEcCtD
Lercanidipine—Insomnia—Methotrexate—hematologic cancer	2.35e-05	7.42e-05	CcSEcCtD
Lercanidipine—Chest pain—Doxorubicin—hematologic cancer	2.35e-05	7.41e-05	CcSEcCtD
Lercanidipine—Myalgia—Doxorubicin—hematologic cancer	2.35e-05	7.41e-05	CcSEcCtD
Lercanidipine—Arthralgia—Doxorubicin—hematologic cancer	2.35e-05	7.41e-05	CcSEcCtD
Lercanidipine—Anxiety—Doxorubicin—hematologic cancer	2.34e-05	7.38e-05	CcSEcCtD
Lercanidipine—Nausea—Triamcinolone—hematologic cancer	2.34e-05	7.38e-05	CcSEcCtD
Lercanidipine—Paraesthesia—Methotrexate—hematologic cancer	2.34e-05	7.37e-05	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.33e-05	7.36e-05	CcSEcCtD
Lercanidipine—Discomfort—Doxorubicin—hematologic cancer	2.32e-05	7.32e-05	CcSEcCtD
Lercanidipine—Anorexia—Epirubicin—hematologic cancer	2.32e-05	7.32e-05	CcSEcCtD
Lercanidipine—Dyspnoea—Methotrexate—hematologic cancer	2.32e-05	7.31e-05	CcSEcCtD
Lercanidipine—Somnolence—Methotrexate—hematologic cancer	2.31e-05	7.29e-05	CcSEcCtD
Lercanidipine—Dry mouth—Doxorubicin—hematologic cancer	2.3e-05	7.25e-05	CcSEcCtD
Lercanidipine—Hypersensitivity—Prednisone—hematologic cancer	2.29e-05	7.23e-05	CcSEcCtD
Lercanidipine—Dyspepsia—Methotrexate—hematologic cancer	2.29e-05	7.22e-05	CcSEcCtD
Lercanidipine—Hypotension—Epirubicin—hematologic cancer	2.27e-05	7.17e-05	CcSEcCtD
Lercanidipine—Vomiting—Betamethasone—hematologic cancer	2.27e-05	7.17e-05	CcSEcCtD
Lercanidipine—Vomiting—Dexamethasone—hematologic cancer	2.27e-05	7.17e-05	CcSEcCtD
Lercanidipine—Confusional state—Doxorubicin—hematologic cancer	2.27e-05	7.16e-05	CcSEcCtD
Lercanidipine—Decreased appetite—Methotrexate—hematologic cancer	2.26e-05	7.13e-05	CcSEcCtD
Lercanidipine—Rash—Dexamethasone—hematologic cancer	2.25e-05	7.11e-05	CcSEcCtD
Lercanidipine—Rash—Betamethasone—hematologic cancer	2.25e-05	7.11e-05	CcSEcCtD
Lercanidipine—Dermatitis—Dexamethasone—hematologic cancer	2.25e-05	7.1e-05	CcSEcCtD
Lercanidipine—Dermatitis—Betamethasone—hematologic cancer	2.25e-05	7.1e-05	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.25e-05	7.08e-05	CcSEcCtD
Lercanidipine—Fatigue—Methotrexate—hematologic cancer	2.24e-05	7.07e-05	CcSEcCtD
Lercanidipine—Headache—Dexamethasone—hematologic cancer	2.24e-05	7.06e-05	CcSEcCtD
Lercanidipine—Headache—Betamethasone—hematologic cancer	2.24e-05	7.06e-05	CcSEcCtD
Lercanidipine—Asthenia—Prednisone—hematologic cancer	2.23e-05	7.04e-05	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.22e-05	6.99e-05	CcSEcCtD
Lercanidipine—Shock—Doxorubicin—hematologic cancer	2.22e-05	6.99e-05	CcSEcCtD
Lercanidipine—Nervous system disorder—Doxorubicin—hematologic cancer	2.21e-05	6.97e-05	CcSEcCtD
Lercanidipine—Thrombocytopenia—Doxorubicin—hematologic cancer	2.2e-05	6.96e-05	CcSEcCtD
Lercanidipine—Pruritus—Prednisone—hematologic cancer	2.2e-05	6.95e-05	CcSEcCtD
Lercanidipine—Insomnia—Epirubicin—hematologic cancer	2.2e-05	6.94e-05	CcSEcCtD
Lercanidipine—Tachycardia—Doxorubicin—hematologic cancer	2.2e-05	6.93e-05	CcSEcCtD
Lercanidipine—Skin disorder—Doxorubicin—hematologic cancer	2.19e-05	6.9e-05	CcSEcCtD
Lercanidipine—Paraesthesia—Epirubicin—hematologic cancer	2.19e-05	6.89e-05	CcSEcCtD
Lercanidipine—Hyperhidrosis—Doxorubicin—hematologic cancer	2.18e-05	6.87e-05	CcSEcCtD
Lercanidipine—Dyspnoea—Epirubicin—hematologic cancer	2.17e-05	6.84e-05	CcSEcCtD
Lercanidipine—Somnolence—Epirubicin—hematologic cancer	2.16e-05	6.83e-05	CcSEcCtD
Lercanidipine—Anorexia—Doxorubicin—hematologic cancer	2.15e-05	6.77e-05	CcSEcCtD
Lercanidipine—Feeling abnormal—Methotrexate—hematologic cancer	2.14e-05	6.76e-05	CcSEcCtD
Lercanidipine—Dyspepsia—Epirubicin—hematologic cancer	2.14e-05	6.76e-05	CcSEcCtD
Lercanidipine—Diarrhoea—Prednisone—hematologic cancer	2.13e-05	6.72e-05	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Methotrexate—hematologic cancer	2.13e-05	6.71e-05	CcSEcCtD
Lercanidipine—Nausea—Dexamethasone—hematologic cancer	2.12e-05	6.7e-05	CcSEcCtD
Lercanidipine—Nausea—Betamethasone—hematologic cancer	2.12e-05	6.7e-05	CcSEcCtD
Lercanidipine—Decreased appetite—Epirubicin—hematologic cancer	2.12e-05	6.67e-05	CcSEcCtD
Lercanidipine—Hypotension—Doxorubicin—hematologic cancer	2.1e-05	6.64e-05	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.1e-05	6.63e-05	CcSEcCtD
Lercanidipine—Fatigue—Epirubicin—hematologic cancer	2.1e-05	6.62e-05	CcSEcCtD
Lercanidipine—Constipation—Epirubicin—hematologic cancer	2.08e-05	6.57e-05	CcSEcCtD
Lercanidipine—Urticaria—Methotrexate—hematologic cancer	2.07e-05	6.52e-05	CcSEcCtD
Lercanidipine—Dizziness—Prednisone—hematologic cancer	2.06e-05	6.49e-05	CcSEcCtD
Lercanidipine—Abdominal pain—Methotrexate—hematologic cancer	2.06e-05	6.49e-05	CcSEcCtD
Lercanidipine—Body temperature increased—Methotrexate—hematologic cancer	2.06e-05	6.49e-05	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.05e-05	6.47e-05	CcSEcCtD
Lercanidipine—Insomnia—Doxorubicin—hematologic cancer	2.04e-05	6.43e-05	CcSEcCtD
Lercanidipine—Paraesthesia—Doxorubicin—hematologic cancer	2.02e-05	6.38e-05	CcSEcCtD
Lercanidipine—Dyspnoea—Doxorubicin—hematologic cancer	2.01e-05	6.33e-05	CcSEcCtD
Lercanidipine—Feeling abnormal—Epirubicin—hematologic cancer	2.01e-05	6.33e-05	CcSEcCtD
Lercanidipine—Somnolence—Doxorubicin—hematologic cancer	2e-05	6.32e-05	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Epirubicin—hematologic cancer	1.99e-05	6.28e-05	CcSEcCtD
Lercanidipine—Dyspepsia—Doxorubicin—hematologic cancer	1.98e-05	6.25e-05	CcSEcCtD
Lercanidipine—Vomiting—Prednisone—hematologic cancer	1.98e-05	6.24e-05	CcSEcCtD
Lercanidipine—Rash—Prednisone—hematologic cancer	1.96e-05	6.19e-05	CcSEcCtD
Lercanidipine—Dermatitis—Prednisone—hematologic cancer	1.96e-05	6.18e-05	CcSEcCtD
Lercanidipine—Decreased appetite—Doxorubicin—hematologic cancer	1.96e-05	6.18e-05	CcSEcCtD
Lercanidipine—Headache—Prednisone—hematologic cancer	1.95e-05	6.15e-05	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.94e-05	6.13e-05	CcSEcCtD
Lercanidipine—Fatigue—Doxorubicin—hematologic cancer	1.94e-05	6.12e-05	CcSEcCtD
Lercanidipine—Urticaria—Epirubicin—hematologic cancer	1.93e-05	6.1e-05	CcSEcCtD
Lercanidipine—Constipation—Doxorubicin—hematologic cancer	1.93e-05	6.07e-05	CcSEcCtD
Lercanidipine—Abdominal pain—Epirubicin—hematologic cancer	1.92e-05	6.07e-05	CcSEcCtD
Lercanidipine—Body temperature increased—Epirubicin—hematologic cancer	1.92e-05	6.07e-05	CcSEcCtD
Lercanidipine—Hypersensitivity—Methotrexate—hematologic cancer	1.92e-05	6.04e-05	CcSEcCtD
Lercanidipine—Asthenia—Methotrexate—hematologic cancer	1.87e-05	5.89e-05	CcSEcCtD
Lercanidipine—Feeling abnormal—Doxorubicin—hematologic cancer	1.86e-05	5.85e-05	CcSEcCtD
Lercanidipine—Nausea—Prednisone—hematologic cancer	1.85e-05	5.83e-05	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.84e-05	5.81e-05	CcSEcCtD
Lercanidipine—Pruritus—Methotrexate—hematologic cancer	1.84e-05	5.8e-05	CcSEcCtD
Lercanidipine—Hypersensitivity—Epirubicin—hematologic cancer	1.79e-05	5.66e-05	CcSEcCtD
Lercanidipine—Urticaria—Doxorubicin—hematologic cancer	1.79e-05	5.64e-05	CcSEcCtD
Lercanidipine—Body temperature increased—Doxorubicin—hematologic cancer	1.78e-05	5.62e-05	CcSEcCtD
Lercanidipine—Abdominal pain—Doxorubicin—hematologic cancer	1.78e-05	5.62e-05	CcSEcCtD
Lercanidipine—Diarrhoea—Methotrexate—hematologic cancer	1.78e-05	5.61e-05	CcSEcCtD
Lercanidipine—Asthenia—Epirubicin—hematologic cancer	1.75e-05	5.51e-05	CcSEcCtD
Lercanidipine—Pruritus—Epirubicin—hematologic cancer	1.72e-05	5.43e-05	CcSEcCtD
Lercanidipine—Dizziness—Methotrexate—hematologic cancer	1.72e-05	5.43e-05	CcSEcCtD
Lercanidipine—CYP3A7—Metabolism—IDH1—hematologic cancer	1.69e-05	0.00031	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ABCC3—hematologic cancer	1.67e-05	0.000307	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—TXN—hematologic cancer	1.67e-05	0.000307	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GSTO1—hematologic cancer	1.67e-05	0.000307	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—GSTP1—hematologic cancer	1.67e-05	0.000306	CbGpPWpGaD
Lercanidipine—Diarrhoea—Epirubicin—hematologic cancer	1.67e-05	5.25e-05	CcSEcCtD
Lercanidipine—CACNA1C—Metabolism—CYCS—hematologic cancer	1.66e-05	0.000305	CbGpPWpGaD
Lercanidipine—Hypersensitivity—Doxorubicin—hematologic cancer	1.66e-05	5.23e-05	CcSEcCtD
Lercanidipine—CACNA1D—Axon guidance—IL6—hematologic cancer	1.66e-05	0.000305	CbGpPWpGaD
Lercanidipine—Vomiting—Methotrexate—hematologic cancer	1.65e-05	5.22e-05	CcSEcCtD
Lercanidipine—CYP2D6—Metabolism—DCK—hematologic cancer	1.65e-05	0.000304	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ASNS—hematologic cancer	1.65e-05	0.000304	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—B3GAT1—hematologic cancer	1.65e-05	0.000304	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—HSP90AA1—hematologic cancer	1.65e-05	0.000303	CbGpPWpGaD
Lercanidipine—Rash—Methotrexate—hematologic cancer	1.64e-05	5.17e-05	CcSEcCtD
Lercanidipine—Dermatitis—Methotrexate—hematologic cancer	1.64e-05	5.17e-05	CcSEcCtD
Lercanidipine—CYP3A7—Metabolism—SPHK1—hematologic cancer	1.63e-05	0.0003	CbGpPWpGaD
Lercanidipine—Headache—Methotrexate—hematologic cancer	1.63e-05	5.14e-05	CcSEcCtD
Lercanidipine—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	1.62e-05	0.000298	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—MAPK3—hematologic cancer	1.62e-05	0.000297	CbGpPWpGaD
Lercanidipine—Asthenia—Doxorubicin—hematologic cancer	1.62e-05	5.1e-05	CcSEcCtD
Lercanidipine—Dizziness—Epirubicin—hematologic cancer	1.61e-05	5.08e-05	CcSEcCtD
Lercanidipine—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	1.6e-05	0.000294	CbGpPWpGaD
Lercanidipine—Pruritus—Doxorubicin—hematologic cancer	1.59e-05	5.03e-05	CcSEcCtD
Lercanidipine—CACNA1C—Developmental Biology—EP300—hematologic cancer	1.59e-05	0.000292	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—ABCB1—hematologic cancer	1.58e-05	0.00029	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—TGFB1—hematologic cancer	1.57e-05	0.000289	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—UGT1A1—hematologic cancer	1.57e-05	0.000288	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—HDC—hematologic cancer	1.57e-05	0.000288	CbGpPWpGaD
Lercanidipine—Vomiting—Epirubicin—hematologic cancer	1.55e-05	4.88e-05	CcSEcCtD
Lercanidipine—Nausea—Methotrexate—hematologic cancer	1.54e-05	4.87e-05	CcSEcCtD
Lercanidipine—CACNA1C—Developmental Biology—SRC—hematologic cancer	1.54e-05	0.000284	CbGpPWpGaD
Lercanidipine—Diarrhoea—Doxorubicin—hematologic cancer	1.54e-05	4.86e-05	CcSEcCtD
Lercanidipine—Rash—Epirubicin—hematologic cancer	1.53e-05	4.84e-05	CcSEcCtD
Lercanidipine—Dermatitis—Epirubicin—hematologic cancer	1.53e-05	4.84e-05	CcSEcCtD
Lercanidipine—CACNA1D—Metabolism—NCOR1—hematologic cancer	1.53e-05	0.000282	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—GSTM1—hematologic cancer	1.53e-05	0.000282	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—SLC22A1—hematologic cancer	1.53e-05	0.000281	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CRABP1—hematologic cancer	1.53e-05	0.000281	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—FHL2—hematologic cancer	1.53e-05	0.00028	CbGpPWpGaD
Lercanidipine—Headache—Epirubicin—hematologic cancer	1.52e-05	4.81e-05	CcSEcCtD
Lercanidipine—CACNA1C—Axon guidance—HRAS—hematologic cancer	1.52e-05	0.00028	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—VEGFA—hematologic cancer	1.5e-05	0.000276	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—AGRN—hematologic cancer	1.5e-05	0.000275	CbGpPWpGaD
Lercanidipine—Dizziness—Doxorubicin—hematologic cancer	1.49e-05	4.7e-05	CcSEcCtD
Lercanidipine—CACNA1C—Developmental Biology—STAT3—hematologic cancer	1.49e-05	0.000273	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ALOX5—hematologic cancer	1.49e-05	0.000273	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—NRAS—hematologic cancer	1.48e-05	0.000273	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—TNF—hematologic cancer	1.47e-05	0.000269	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—GSTP1—hematologic cancer	1.46e-05	0.000269	CbGpPWpGaD
Lercanidipine—CACNA1C—Axon guidance—IL6—hematologic cancer	1.46e-05	0.000268	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—KRAS—hematologic cancer	1.45e-05	0.000267	CbGpPWpGaD
Lercanidipine—Nausea—Epirubicin—hematologic cancer	1.45e-05	4.56e-05	CcSEcCtD
Lercanidipine—CYP3A7—Metabolism—NUP98—hematologic cancer	1.44e-05	0.000265	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CDA—hematologic cancer	1.43e-05	0.000263	CbGpPWpGaD
Lercanidipine—Vomiting—Doxorubicin—hematologic cancer	1.43e-05	4.52e-05	CcSEcCtD
Lercanidipine—CACNA1C—Developmental Biology—MAPK3—hematologic cancer	1.42e-05	0.000261	CbGpPWpGaD
Lercanidipine—Rash—Doxorubicin—hematologic cancer	1.42e-05	4.48e-05	CcSEcCtD
Lercanidipine—CYP3A5—Metabolism—IDH2—hematologic cancer	1.42e-05	0.000261	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—HMMR—hematologic cancer	1.42e-05	0.000261	CbGpPWpGaD
Lercanidipine—Dermatitis—Doxorubicin—hematologic cancer	1.42e-05	4.48e-05	CcSEcCtD
Lercanidipine—Headache—Doxorubicin—hematologic cancer	1.41e-05	4.45e-05	CcSEcCtD
Lercanidipine—CYP3A7—Metabolism—ADCY7—hematologic cancer	1.4e-05	0.000257	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—NCOA3—hematologic cancer	1.4e-05	0.000257	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—NUP214—hematologic cancer	1.39e-05	0.000255	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—ABCB1—hematologic cancer	1.39e-05	0.000255	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—TGFB1—hematologic cancer	1.38e-05	0.000254	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PC—hematologic cancer	1.38e-05	0.000253	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—MTR—hematologic cancer	1.36e-05	0.00025	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ABCG2—hematologic cancer	1.36e-05	0.00025	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—MTHFR—hematologic cancer	1.35e-05	0.000249	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GMPS—hematologic cancer	1.35e-05	0.000248	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PHYH—hematologic cancer	1.35e-05	0.000248	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—FTCD—hematologic cancer	1.35e-05	0.000248	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—NCOR1—hematologic cancer	1.35e-05	0.000247	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—GSTM1—hematologic cancer	1.35e-05	0.000247	CbGpPWpGaD
Lercanidipine—Nausea—Doxorubicin—hematologic cancer	1.34e-05	4.22e-05	CcSEcCtD
Lercanidipine—CYP3A7—Metabolism—ENO2—hematologic cancer	1.33e-05	0.000245	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ARNTL—hematologic cancer	1.33e-05	0.000245	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GBA—hematologic cancer	1.33e-05	0.000245	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—SLC35B2—hematologic cancer	1.33e-05	0.000245	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CA9—hematologic cancer	1.3e-05	0.000238	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ACP5—hematologic cancer	1.3e-05	0.000238	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GSTT1—hematologic cancer	1.29e-05	0.000238	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—TNF—hematologic cancer	1.29e-05	0.000237	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—NCOR2—hematologic cancer	1.28e-05	0.000235	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—KRAS—hematologic cancer	1.28e-05	0.000235	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—SDC1—hematologic cancer	1.26e-05	0.000232	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—HRAS—hematologic cancer	1.24e-05	0.000227	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.24e-05	0.000227	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—IDH1—hematologic cancer	1.22e-05	0.000224	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—MTAP—hematologic cancer	1.22e-05	0.000224	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ABCC3—hematologic cancer	1.21e-05	0.000222	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—TXN—hematologic cancer	1.21e-05	0.000222	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GSTO1—hematologic cancer	1.21e-05	0.000222	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—MTHFR—hematologic cancer	1.19e-05	0.000219	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—IL6—hematologic cancer	1.18e-05	0.000217	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—SPHK1—hematologic cancer	1.18e-05	0.000217	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PIK3CG—hematologic cancer	1.14e-05	0.000209	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—UGT1A1—hematologic cancer	1.13e-05	0.000208	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CRABP1—hematologic cancer	1.1e-05	0.000203	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—SLC22A1—hematologic cancer	1.1e-05	0.000203	CbGpPWpGaD
Lercanidipine—CACNA1D—Developmental Biology—AKT1—hematologic cancer	1.09e-05	0.000201	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—HRAS—hematologic cancer	1.09e-05	0.0002	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—FHL2—hematologic cancer	1.09e-05	0.000199	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.08e-05	0.000198	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—DCK—hematologic cancer	1.08e-05	0.000198	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ASNS—hematologic cancer	1.08e-05	0.000198	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CD44—hematologic cancer	1.08e-05	0.000198	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—NQO1—hematologic cancer	1.08e-05	0.000198	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ALOX5—hematologic cancer	1.08e-05	0.000198	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—AGRN—hematologic cancer	1.06e-05	0.000196	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—CREBBP—hematologic cancer	1.05e-05	0.000194	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—NUP98—hematologic cancer	1.04e-05	0.000191	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—IL6—hematologic cancer	1.04e-05	0.000191	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—HDC—hematologic cancer	1.02e-05	0.000188	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CYCS—hematologic cancer	1.02e-05	0.000187	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—HSP90AA1—hematologic cancer	1.01e-05	0.000186	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ADCY7—hematologic cancer	1.01e-05	0.000186	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—NCOA3—hematologic cancer	1.01e-05	0.000186	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—IDH2—hematologic cancer	1.01e-05	0.000185	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—HMMR—hematologic cancer	1.01e-05	0.000185	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—NUP214—hematologic cancer	1e-05	0.000184	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PIK3CD—hematologic cancer	1e-05	0.000184	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PIK3CG—hematologic cancer	9.99e-06	0.000184	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—ALB—hematologic cancer	9.87e-06	0.000181	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—MTR—hematologic cancer	9.83e-06	0.000181	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ABCG2—hematologic cancer	9.83e-06	0.000181	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ENO2—hematologic cancer	9.64e-06	0.000177	CbGpPWpGaD
Lercanidipine—CACNA1C—Developmental Biology—AKT1—hematologic cancer	9.59e-06	0.000176	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ARNTL—hematologic cancer	9.48e-06	0.000174	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PIK3R1—hematologic cancer	9.44e-06	0.000174	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CDA—hematologic cancer	9.36e-06	0.000172	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GSTT1—hematologic cancer	9.35e-06	0.000172	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—CREBBP—hematologic cancer	9.27e-06	0.00017	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ACP5—hematologic cancer	9.23e-06	0.00017	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CA9—hematologic cancer	9.23e-06	0.00017	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—SDC1—hematologic cancer	9.14e-06	0.000168	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—NCOR2—hematologic cancer	9.11e-06	0.000167	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PC—hematologic cancer	9.01e-06	0.000166	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GSTP1—hematologic cancer	8.97e-06	0.000165	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PIK3CD—hematologic cancer	8.79e-06	0.000161	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PIK3CB—hematologic cancer	8.72e-06	0.00016	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GBA—hematologic cancer	8.7e-06	0.00016	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—SLC35B2—hematologic cancer	8.7e-06	0.00016	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—IDH1—hematologic cancer	8.68e-06	0.000159	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—ALB—hematologic cancer	8.67e-06	0.000159	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GSTO1—hematologic cancer	8.58e-06	0.000158	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—TXN—hematologic cancer	8.58e-06	0.000158	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ABCC3—hematologic cancer	8.58e-06	0.000158	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ABCB1—hematologic cancer	8.49e-06	0.000156	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—SPHK1—hematologic cancer	8.39e-06	0.000154	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PIK3R1—hematologic cancer	8.3e-06	0.000152	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—NCOR1—hematologic cancer	8.24e-06	0.000151	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—GSTM1—hematologic cancer	8.24e-06	0.000151	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—UGT1A1—hematologic cancer	8.06e-06	0.000148	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—MTAP—hematologic cancer	7.96e-06	0.000146	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—SLC22A1—hematologic cancer	7.85e-06	0.000144	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CRABP1—hematologic cancer	7.85e-06	0.000144	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CD44—hematologic cancer	7.77e-06	0.000143	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—NQO1—hematologic cancer	7.77e-06	0.000143	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PIK3CB—hematologic cancer	7.66e-06	0.000141	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ALOX5—hematologic cancer	7.65e-06	0.000141	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PTEN—hematologic cancer	7.53e-06	0.000138	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—NUP98—hematologic cancer	7.4e-06	0.000136	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CYCS—hematologic cancer	7.36e-06	0.000135	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	7.31e-06	0.000134	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—MTHFR—hematologic cancer	7.28e-06	0.000134	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ADCY7—hematologic cancer	7.19e-06	0.000132	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—NCOA3—hematologic cancer	7.19e-06	0.000132	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—EP300—hematologic cancer	7.18e-06	0.000132	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—NUP214—hematologic cancer	7.14e-06	0.000131	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—FHL2—hematologic cancer	7.09e-06	0.00013	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ABCG2—hematologic cancer	6.99e-06	0.000129	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—MTR—hematologic cancer	6.99e-06	0.000129	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—AGRN—hematologic cancer	6.96e-06	0.000128	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ENO2—hematologic cancer	6.86e-06	0.000126	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GSTT1—hematologic cancer	6.65e-06	0.000122	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PTEN—hematologic cancer	6.62e-06	0.000122	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—IDH2—hematologic cancer	6.6e-06	0.000121	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—HMMR—hematologic cancer	6.6e-06	0.000121	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—SDC1—hematologic cancer	6.5e-06	0.000119	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GSTP1—hematologic cancer	6.48e-06	0.000119	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—EP300—hematologic cancer	6.31e-06	0.000116	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ARNTL—hematologic cancer	6.2e-06	0.000114	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ABCB1—hematologic cancer	6.14e-06	0.000113	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PIK3CG—hematologic cancer	6.12e-06	0.000112	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CA9—hematologic cancer	6.03e-06	0.000111	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ACP5—hematologic cancer	6.03e-06	0.000111	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—GSTM1—hematologic cancer	5.96e-06	0.00011	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—NCOR1—hematologic cancer	5.96e-06	0.00011	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—NCOR2—hematologic cancer	5.95e-06	0.000109	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—CREBBP—hematologic cancer	5.67e-06	0.000104	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—IDH1—hematologic cancer	5.67e-06	0.000104	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—TXN—hematologic cancer	5.61e-06	0.000103	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GSTO1—hematologic cancer	5.61e-06	0.000103	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ABCC3—hematologic cancer	5.61e-06	0.000103	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CD44—hematologic cancer	5.53e-06	0.000102	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—NQO1—hematologic cancer	5.53e-06	0.000102	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—SPHK1—hematologic cancer	5.49e-06	0.000101	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PIK3CD—hematologic cancer	5.38e-06	9.89e-05	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—PIK3CA—hematologic cancer	5.31e-06	9.77e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—ALB—hematologic cancer	5.31e-06	9.76e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	5.27e-06	9.69e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—MTHFR—hematologic cancer	5.27e-06	9.68e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CYCS—hematologic cancer	5.23e-06	9.61e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	5.2e-06	9.55e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	5.13e-06	9.43e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CRABP1—hematologic cancer	5.13e-06	9.43e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PIK3R1—hematologic cancer	5.08e-06	9.34e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ALOX5—hematologic cancer	5e-06	9.19e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—NUP98—hematologic cancer	4.84e-06	8.9e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.7e-06	8.64e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.7e-06	8.64e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PIK3CB—hematologic cancer	4.69e-06	8.62e-05	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—PIK3CA—hematologic cancer	4.67e-06	8.58e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—NUP214—hematologic cancer	4.67e-06	8.58e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GSTP1—hematologic cancer	4.61e-06	8.47e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—MTR—hematologic cancer	4.57e-06	8.4e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ABCG2—hematologic cancer	4.57e-06	8.4e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ENO2—hematologic cancer	4.48e-06	8.24e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PIK3CG—hematologic cancer	4.42e-06	8.13e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ABCB1—hematologic cancer	4.36e-06	8.02e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GSTT1—hematologic cancer	4.35e-06	7.99e-05	CbGpPWpGaD
Lercanidipine—CACNA1D—Metabolism—AKT1—hematologic cancer	4.34e-06	7.98e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—SDC1—hematologic cancer	4.25e-06	7.81e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—GSTM1—hematologic cancer	4.24e-06	7.79e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—NCOR1—hematologic cancer	4.24e-06	7.79e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—CREBBP—hematologic cancer	4.1e-06	7.54e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PTEN—hematologic cancer	4.05e-06	7.45e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PIK3CD—hematologic cancer	3.89e-06	7.15e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—EP300—hematologic cancer	3.86e-06	7.1e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—ALB—hematologic cancer	3.84e-06	7.06e-05	CbGpPWpGaD
Lercanidipine—CACNA1C—Metabolism—AKT1—hematologic cancer	3.81e-06	7.01e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—MTHFR—hematologic cancer	3.74e-06	6.88e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PIK3R1—hematologic cancer	3.67e-06	6.75e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CD44—hematologic cancer	3.61e-06	6.64e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—NQO1—hematologic cancer	3.61e-06	6.64e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CYCS—hematologic cancer	3.42e-06	6.28e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.4e-06	6.24e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PIK3CB—hematologic cancer	3.39e-06	6.23e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	3.15e-06	5.78e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.01e-06	5.54e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PTEN—hematologic cancer	2.93e-06	5.38e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.92e-06	5.36e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—PIK3CA—hematologic cancer	2.86e-06	5.25e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.85e-06	5.24e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—EP300—hematologic cancer	2.79e-06	5.13e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.77e-06	5.09e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.77e-06	5.09e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.77e-06	5.08e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—ALB—hematologic cancer	2.73e-06	5.02e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.61e-06	4.8e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.45e-06	4.5e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.41e-06	4.43e-05	CbGpPWpGaD
Lercanidipine—CYP3A7—Metabolism—AKT1—hematologic cancer	2.34e-06	4.29e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PTEN—hematologic cancer	2.08e-06	3.83e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—PIK3CA—hematologic cancer	2.07e-06	3.8e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.06e-06	3.78e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—EP300—hematologic cancer	1.99e-06	3.65e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.91e-06	3.5e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.81e-06	3.32e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—ALB—hematologic cancer	1.78e-06	3.28e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.71e-06	3.14e-05	CbGpPWpGaD
Lercanidipine—CYP3A5—Metabolism—AKT1—hematologic cancer	1.69e-06	3.1e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.58e-06	2.9e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.47e-06	2.7e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PTEN—hematologic cancer	1.36e-06	2.5e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—EP300—hematologic cancer	1.3e-06	2.39e-05	CbGpPWpGaD
Lercanidipine—CYP2D6—Metabolism—AKT1—hematologic cancer	1.2e-06	2.21e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	9.61e-07	1.77e-05	CbGpPWpGaD
Lercanidipine—CYP3A4—Metabolism—AKT1—hematologic cancer	7.85e-07	1.44e-05	CbGpPWpGaD
